Press Releases 

Helomics to Present at BIO CEO & Investor Conference

Helomics Corporation, a privately held comprehensive personalized healthcare company that develops innovative next generation diagnostics for the oncology field, announced today that it will present at BIO CEO & Investor Conference 2016 to be held February 8-9, 2016 at the Waldorf Astoria New York. Neil Campbell, President and CEO of Helomics, will provide an overview of the Company’s personalized tumor profiling business during his live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Event: BIO CEO & Investor Conference Date: Tuesday, February 9, 2016 Time: 1:45pm (Eastern Time) Location: Waldorf Astoria;

Helomics to Present at the Personalized Medicine World Conference 2016

Helomics Corporation, a privately-held comprehensive personalized healthcare company that provides comprehensive tumor profiling utilizing proprietary live cell and fixed cell products and services, announced today that the Company is scheduled to present at thePersonalized Medicine World Conference taking place in Silicon Valley on January 24-27, 2016. Neil Campbell, President and Chief Executive Officer of Helomics, will provide an overview of the personalized healthcare landscape, the Company’s business and its comprehensive tumor profiling technologies during his presentation and will be available to participate in one-on-one meetings. Event: Personalized Medicine World Conference Date:

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon